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psinR is a clathrin-coated vesicle (CCV) enriched 70-kD
protein that binds to phosphatidylinositol-4-phosphate,
clathrin, and the gamma appendage domain of the
adaptor protein complex 1 (AP1). In cells, its distribution
overlaps with the perinuclear pool of clathrin and AP1
adaptors. Overexpression disrupts the CCV-dependent
trafﬁcking of cathepsin D from the trans-Golgi network to
lysosomes and the incorporation of mannose-6-phosphate
receptors into CCVs. These biochemical and cell biological
data point to a role for epsinR in AP1/clathrin budding
E
 
events in the cell, just as epsin1 is involved in the budding
of AP2 CCVs. Furthermore, we show that two gamma
appendage domains can simultaneously bind to epsinR with
 
afﬁnities of 0.7 and 45 
 
 
 
M, respectively. Thus, potentially,
two AP1 complexes can bind to one epsinR. This high afﬁnity
binding allowed us to identify a consensus binding motif of
the form DFxDF, which we also ﬁnd in 
 
 
 
-synergin and use
to predict that an uncharacterized EF-hand–containing
protein will be a new gamma binding partner.
 
Introduction
 
Clathrin-coated buds have been observed on the plasma
membrane, endosomes, the TGN, and on various other
intermediate trafficking compartments (Stoorvogel et al.,
1996; Zhu et al., 2001). They serve to package cargo from a
donor compartment into transport vesicles.
To recruit cargo, a number of adaptor proteins are
needed. These can be classified into four subunit polymeric
adaptor protein complexes (APs;* AP1, AP2, AP3, and AP4;
Hirst and Robinson, 1998; Boehm and Bonifacino, 2002)
and monomeric adaptors, e.g., Golgi-localized, gamma-
ear–containing ADP-ribosylation factor–binding proteins
(GGAs; Dell’Angelica et al., 2000; Hirst et al., 2000). Each
polymeric AP contains a specific 
 
 
 
-subunit that recognizes
variations of a sequence motif (Yxx
 
 
 
) on the cytoplasmic
tails of cargo molecules (Kirchhausen et al., 1997; Owen and
Evans, 1998). Each AP also contains two large homologous
subunits (
 
 
 
 
 
 
 
 
 
 
 
1 in the AP1 complex, 
 
 
 
 
 
 
 
 
 
 
 
2 in the AP2
complex, and 
 
 
 
 
 
 
 
 
 
 
 
3 in the AP3 complex) whose appendage
domains bind to core and accessory proteins necessary for
clathrin-coated vesicle
 
 (
 
CCV) formation. The 
 
 
 
-appendage
has been shown to bind proteins that contain DxF motifs,
normally in multiple copies (Owen et al., 1999, 2000; Brett
et al., 2002), and as part of this paper, we investigate the
motif for binding the 
 
 
 
-appendage. AP2 adaptor complexes
are found predominantly at the plasma membrane, whereas
AP1 complexes are found concentrated at the TGN. The
monomeric GGAs have recently been shown to bind cargo
via a VHS domain (Doray et al., 2002; Misra et al., 2002;
Shiba et al., 2002), and they also have a domain with very
strong homology to the 
 
 
 
-adaptin appendage.
The AP of 180
 
 
 
kD (AP180) is a brain-enriched clathrin/
adaptor-binding protein that promotes clathrin assembly on
membranes (Ford et al., 2001). It is not a conventional
adaptor protein in that it does not link cargo into the clathrin
 
cage. The protein is essential for CCV formation in 
 
Drosophila
 
(Zhang et al., 1998) and in 
 
Caenorhabditis elegans
 
 (Nonet et
al., 1999), and overexpression of the COOH-terminal domain
blocks clathrin-coated budding events (Ford et al., 2001).
The AP180 NH
 
2
 
-terminal homology (ANTH) domain of
AP180 and its ubiquitous homologue, CALM, directs bind-
ing to PtdIns(4,5)P
 
2
 
 in the membrane.
By domain analysis, the epsin family of proteins are close
relatives of the AP180 family. They both have lipid-binding
domains at the NH
 
2
 
 terminus and clathrin/adaptor-binding
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domains centrally located. However, they are distinct in that
the AP180 NH
 
2
 
-terminal homology (ANTH) domain binds
lipids on its surface, coordinating the headgroup via a
KxxKxH motif, whereas the epsin-NH
 
2
 
-terminal homology
(ENTH) domain binds lipids in a pocket using residues
spread over the first three helices. On binding, the first helix
of the epsin ENTH domain folds around the lipid headgroup
and exposes a hydrophobic surface on the outer surface of this
new helix. We have proposed that on binding to membranes,
this new helix buries itself between the lipid headgroups,
pushing the lipids apart and thus promoting membrane cur-
vature in the clathrin-coated bud (Ford et al., 2002). As this
will need to be a coordinated event, the COOH terminus of
 
epsin1 binds to both clathrin and the AP2 complex, thus in-
ducing the curvature in newly forming coated pits.
Epsins were originally identified as Eps15-interacting pro-
teins, but the family is now better described as being ENTH
domain (phosphatidylinositol phosphate [PtdInsP] binding)
proteins with clathrin/adaptor binding sequences. Epsins 1
and 2 are brain-enriched (Rosenthal et al., 1999), whereas
epsin3 is expressed in wounded epithelia (Spradling et al.,
2001). Previously, we identified another epsin in the database
(Ford et al., 2002) that is more distantly related to epsins 1–3
in that it does not have any Eps15-binding motifs (NPFs),
and so is not a classical “
 
eps
 
in,” and thus, we named it epsinR
(for epsin-related protein). The ENTH domain of epsinR is
Figure 1. The ENTH domain of epsinR. 
(A) The ENTH domain of epsinR was 
modeled on epsin1 ENTH with Ins(1,4,5)P3 
bound. The major difference in surface 
electrostatic potential (red   10 kT e
 1; 
blue   10 kT e
 1) is in the PtdInsP 
binding pocket where several positively 
charged residues are missing in epsinR 
ENTH domain. (B) Ribbon diagram of 
the modeled epsinR ENTH domain 
showing the residues in the binding 
pocket and the succession of hydrophobic 
residues on the outer surface of helix 
zero ( 0), just like in epsin1 ENTH 
domain. (C) Sequence homologies 
between epsin1 homologues and epsinR 
homologues. Both Drosophila (D) and C. 
elegans (Ce) have one homologue of 
each, but humans have three homologues 
of epsin1 (1–3), and yeast (Sc, Saccharo-
myces cerevisiae) also has multiple 
homologues. Hydrophobic residues on 
the outer surface of helix zero are 
marked in yellow. Conserved (blue) and 
nonconserved (green) Ptd(4,5)P2 binding 
residues and other major differences 
(orange) are marked. Some of the key 
residues in the human epsinR sequence 
referred to in the paper are numbered. 
(D) Domain structure of epsin1 compared 
with epsinR. Clathrin binding motifs 
(pink), DPW/DLF adaptor binding motifs 
(purple) and regions of alternative splicing 
(dotted lines) are shown. The splice site 
at amino acid 460 is an insert of the 
residues QPLQNVSTVLQKPNPLYN. 
Below are shown all the constructs, 
mutations, truncations and peptides used 
in the paper. The ubiquitin-interacting 
motifs (UIMs) and the Eps15 binding 
motifs (NPFs) found in epsin1 are not 
present in epsinR. We also know that 
there are additional clathrin binding 
motifs in epsinR (at least one in the N2 
domain) that we have not mapped.T
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conserved, although the lipid specificity is predicted to be dif-
ferent (Ford et al., 2002). The clathrin/adaptor binding do-
main is also conserved, although the motifs present are dis-
tinctly different (Fig. 1 D). EpsinR does not have the
ubiquitin interacting motifs present in epsins 1–3 that bind to
ubiquitin and are essential for the monoubiquitination of the
protein (Oldham et al., 2002; Polo et al., 2002). EpsinR ho-
mologues are also present in other species, including 
 
Dro-
sophila
 
 and 
 
C. elegans
 
 (Fig. 1 C), and have no NPF motifs, but
have multiple DxF motifs in place of the multiple DPWs in
the epsin1 homologues. In this paper, we investigate the func-
tion of mammalian epsinR in vesicle budding events.
 
Results
 
EpsinR ENTH domain binds PtdIns(4)P
 
The ENTH domain of epsinR is predicted to have essentially
the same structure as epsin1 (48% sequence identity in this
domain), but some of the key PtdIns(4,5)P
 
2
 
 binding residues
(R7, R8, and K11) are not conserved. R8 from epsin1 is re-
placed by D12, and N30 is replaced by D34 (Fig. 1). We pre-
dicted that epsinR should bind a monophosphate PtdInsP
rather than PtdIns(4,5)P
 
2
 
 (Ford et al., 2002). The lower over-
all positive charge density in the binding pocket can readily be
seen from a model based on epsin1 ENTH domain (Fig. 1 A).
Epsin1 ENTH domain binds to PtdIns(4,5)P
 
2
 
 in lipo-
some-binding assays and by isothermal titration calorimetry
(ITC) with a low micromolar affinity (Itoh et al., 2001;
Ford et al., 2002). In liposome-binding experiments and in
overlay assays, epsinR showed a very weak preference for li-
posomes containing PtdIns(4)P while also binding to Ptd-
Ins(5)P (Fig. 2). This was similar to the specificity of the
PH domain of oxysterol binding protein (OSBP; Levine and
Munro, 2002) that is targeted in vivo to Golgi membranes
(also for epsinR; see Fig. 6 and Fig. S1, available at http://
www.jcb.org/cgi/content/full/jcb.200208023/DC1). Mu-
tants of epsinR showed no binding in the overlay assay when
Figure 2. EpsinR binds to PtdIns(4)P and PtdIns(5)P in vitro. 
(A) Coomassie-stained gel of liposome-binding assays with epsinR 
ENTH domain, the PtdIns(4)P targeted GFP tagged PH domain of 
OSBP, and the PtdIns(3)P targeted PX domain of p40
phox. Pellet (P) 
and supernatant (S). (B) PtdInsP strips confirm the lipid specificity of 
epsin1 ENTH domain for PtdIns(4,5)P2 and show that epsinR prefers 
PtdInsPs with a lower charge density. The R29L mutation weakens 
the interaction, and with the double mutation D34G   R67L, we 
lose the 4P and 5P interactions. OSBP also shows a very similar 
specificity to epsinR ENTH domain. The labeling on the first strip 
applies to the other panels.
Figure 3. EpsinR, a ubiquitous protein enriched in CCVs. (A) Puri-
fication of rat liver and brain CCVs. A stronger adaptor band is seen 
by Coomassie staining in the liver CCV preparation, although by 
electron microscopy, the liver CCVs are not as pure as the brain 
CCVs (not depicted). (B) Brain fractions were blotted for various 
CCV-enriched and -nonenriched proteins, and these were compared 
with epsin1 and epsinR in the same preparation. Blots for epsinR 
and the cation-independent M6P receptor are also shown for liver 
fractions. (C) Brain-specific distribution of epsin1 compared with 
the ubiquitous distribution of epsinR. Equal concentrations of rat 
tissue were loaded.T
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tested using equivalent protein concentrations and incuba-
tion times (Fig. 2). In vivo, PtdIns(4)P is thought to be
more TGN-enriched, and PtdIns 4-kinase activity is found
on the Golgi (Godi et al., 1999), whereas PtdIns(5)P has not
been localized in cells. The weak binding to lipids in vitro
may well mean that multimerization and/or the presence of
other proteins may play a role in membrane recruitment (see
Discussion). We have limited evidence for self-association of
epsinR from pulldown experiments (see Fig. 4 D and un-
published data), and it is therefore possible that endogenous
epsinR may have a higher avidity for membranes than ob-
served for the monomeric ENTH domain.
 
EpsinR enrichment in CCVs
 
EpsinR has a ubiquitous tissue distribution both on North-
ern blots and by Western blots (Fig. 3 C; refer to Materials
and methods for antibody used). Epsin1 is brain-enriched
and colocalizes with plasma membrane clathrin and AP2
adaptors in cells, but is not enriched in CCVs (Chen et al.,
1998; Ford et al., 2002). In contrast, epsinR showed a good
enrichment in both brain and liver CCVs (Fig. 3, A and B).
There are numerous possible explanations for different en-
richments of epsins in brain CCVs, one being the activity of
the major brain lipid phosphatase, synaptojanin (McPherson
et al., 1996). Synaptojanin activity in CCVs would result in
the loss of the 5
 
 
 
 phosphate from PtdIns(4,5)P
 
2
 
, which
would only lead to the release of epsin1 and the AP2 com-
plex, while not having as profound an effect on epsinR and
AP1. We also found endogenous and overexpressed epsinR
enrichment in Golgi fractions using the Balch purification
procedure (Balch et al., 1984) and a de-enrichment of the
lipid-binding mutant epsinR-D34G (Fig. S1). On the basis
of these combined results, we can conclude that epsinR is a
widely distributed protein enriched in both CCVs and Golgi
fractions.
 
EpsinR binds clathrin, APs, and GGAs
 
EpsinR contains a clathrin/adaptor-binding domain. Con-
structs encompassing this domain bound to clathrin and to
AP1 and AP2 complexes (Fig. 4 A; blots for 
 
 
 
-, 
 
 
 
-, and
 
 
 
-adaptins), but not to AP3 complexes (
 
 
 
-adaptin blot, not
depicted). The AP1 specificity of the epsinR N1 construct was
notable in contrast to the other control proteins. The major
clathrin/adaptin binding was further localized, with trunca-
tions and point mutagenesis (Fig. 4 B; see Fig. 1 D for con-
structs used), to the N3 construct of epsinR, with some fur-
ther clathrin binding found in the N2 construct (Fig. 4 A
and unpublished data). The N3 construct contains three
DLF motifs that are potentially 
 
 
 
- and 
 
 
 
-appendage binding
sequences (Owen et al., 1999, 2000; Brett et al., 2002). Point
Figure 4. Clathrin and AP1 adaptors 
bind to epsinR. (A) Epsin1 and epsinR 
constructs were tested for binding to 
adaptors, clathrin, and AP180 in rat 
brain extract. Epsin1, Eps15 and AP180 
all bind to  - and  -adaptins but only 
epsinR binds to  -adaptin (asterisk). All 
constructs were GST-tagged, and  /  
indicates the presence/absence of brain 
extract. (B) Truncations of N1 narrowed 
the major clathrin/adaptor-binding 
domain to 291–426 (N3), and further 
truncations abolish clathrin and then 
adaptor binding (Coomassie-stained 
gel). GGAs also bind to the N3 con-
struct, and the first deletion affects the 
interaction (blot). Point mutagenesis 
shows that D422R primarily affects 
clathrin binding over adaptor binding 
while AP2 adaptors are affected by the 
D349 mutation. AP1 adaptors are 
affected by D349 and D371 mutations. 
GGA binding does not follow the same 
pattern as clathrin or the multimeric 
adaptors. (C) Full-length Myc-epsin1 and 
Myc-epsinR expressed in COS cells bind 
to the GST-appendage domains of  -,
 -, and  -adaptin, but not the L762E 
 -adaptin appendage. (D) GST constructs 
of GGA1 and GGA2 appendage domains 
and the N3 construct of epsinR bind to 
full-length epsinR in brain extract. (E) 
Clathrin assembly is not promoted by 
the N3 domain of epsinR at neutral pH. 
Controls with  -adaptin appendage   
hinge domain and full-length AP180 
both show different extents of assembly. 
Clathrin in pellet (P) and supernatant (S) 
fractions after spinning are shown.T
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mutagenesis of these motifs had no major effect on adaptor
interactions, but the D349R mutation did affect AP2 bind-
ing, and the shortening of the domain to G345 also affected
AP binding (Fig. 4 B). There are at least two possible clathrin
interaction motifs in the N3 construct. Mutagenesis of the
first motif (D325R and D328R in 
 
D
 
LV
 
D
 
LF) had a weak ef-
fect on clathrin binding, but mutagenesis of the second
(D422R in 
 
D
 
LFDLM) had a major effect on clathrin bind-
ing (Fig. 4 B). Truncations also pointed to the same motif as
being important for clathrin binding.
Given the binding of epsinR to adaptor complexes in
brain and COS cell extracts, we next tested which append-
age domains were responsible for the interactions (Fig. 4 C).
In this experiment, Myc-tagged epsins were overexpressed in
COS cells and GST-appendage domains were used to fish
the proteins out. All appendage domains tested bound to both
epsin1 and epsinR; however, 
 
 
 
-appendage has a distinct
preference for epsinR. The L762E mutant of the 
 
 
 
-append-
age (Kent et al., 2002) abolished the interaction (Fig. 4
C). This preference for the 
 
 
 
-appendage was confirmed by
ITC where the affinity for the 
 
 
 
-appendage was much
weaker than for the 
 
 
 
- and 
 
 
 
-appendages (Fig. 5). For both
the 
 
 
 
- and 
 
 
 
-appendages, the binding stoichiometry was 2:1,
and we were thus able to fit a curve describing two bind-
ing sites to the data. These were very robust fits, giving a site
with a submicromolar affinity and a further lower affinity
site in each case. These experiments also show that multiple
appendage domains can interact at the same time. GGAs,
which have a 
 
 
 
-adaptin appendage homology domain would
also be predicted to bind epsinR. GST-GGA appendage do-
mains interacted with epsinR (Fig. 4 D), and the reverse ex-
periment also showed that GST-epsinR N1 construct bound
to GGAs 1 and 2 (Fig. 4 B and unpublished data). However,
despite the very high conservation of critical residues be-
tween the predicted binding sites in GGAs and 
 
 
 
-adaptin
appendages, deletion constructs point to clear differences in
the binding specificities (Fig. 4 B). The affinity of GGA1 for
the epsinR N3 construct was also much lower than the affin-
ity of the 
 
 
 
-appendage (Fig. 5). Of all the appendage do-
mains tested the much higher affinities of 
 
 
 
- and 
 
 
 
-append-
ages for epsinR imply that the AP1 complex is the major
interacting adaptor.
 
Identification of the 
 
 
 
-appendage binding site
 
EpsinR shows a clear preference over epsin 1 for AP1 adap-
tors in brain cytosol (Fig. 4 A), and thus, there must be some
additional recognition sequences for 
 
 
 
-adaptins (an AP1-
specific subunit) in the epsinR protein. An unresolved issue
in the recent crystallization studies on 
 
 
 
-adaptin appendage
domain (Kent et al., 2002; Nogi et al., 2002) is the identity
of this sequence. From comparisons of the appendage do-
main structures, the 
 
 
 
-appendage is missing the platform
domains to which ligands bind in both 
 
 
 
- and 
 
 
 
-append-
ages. Thus, the binding motif for the 
 
 
 
-appendage is not
likely to follow the DxF pattern (Owen et al., 1999, 2000).
Based on the truncation of N1, we saw a slight reduction
in AP1 binding (as assessed by blotting for 
 
 
 
-adaptin) with a
stop mutation after N379 and a major reduction in binding
with a stop mutation after G345. We noted the presence of
two DFG sequences sequentially deleted by these trunca-
tions. Point mutants of the sequences D349R and D371R
both reduced AP1 binding. The presence of two binding
sites is consistent with the affinity measurements for the N3
construct with the 
 
 
 
-appendage domain (Fig. 5). Mutagene-
sis of both D349R and D371R in N3 both greatly weakened
the high affinity interaction, implying that this may be due
to secondary folding. However, secondary structure analysis
of the N3 construct by CD spectroscopy showed that it is
largely unstructured, though there is a mild change in the
presence of 
 
 
 
-appendage (Fig. S2).
Figure 5. Two  -adaptin appendage 
domains can bind simultaneously with 
high affinity to epsinR. (A) Affinity 
measurement by calorimetric titrations 
for  -,  -, and  -appendage domains 
and GGA appendage domain with 
epsinR N3 constructs. Where the 
stoichiometry of the interaction was 2:1, 
the data showed a robust fit to a two-site 
model, and the KDs for both sites are 
shown. The bold lettering indicates the 
protein in the syringe. (B) Peptides from 
epsinR and  -synergin binding to the 
 -adaptin appendage domain. Profiles 
of typical calorimetric titrations and the 
integrated normalized data are shown 
on the right. A comprehensive table of 
calorimetric data is available in Table SI.T
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To investigate AP interactions further, we made peptides
for direct interaction studies (see Fig. 1 D for peptide loca-
tions). The P1 peptide contains the first DLF motif. It did not
bind to the  -,  -, or  -appendages (Fig. 5), and mutagenesis
of D325 and D328 had no effect on AP1 binding (Fig. 4 B).
Peptides P2, P3, and P4 are overlapping; P2 and P3 contain
the second DLF motif and P3 and P4 contain the first DFG
sequence. All three peptides bound weakly to the  -append-
age, thus excluding the possibility that the DFG alone is re-
sponsible for the interaction. P3 and P4 both interacted with
the  -appendage but only P3 with the  -appendage domain.
The P5 peptide containing the second DFG sequence bound
 -appendage with the highest affinity (48  M) although still
much weaker than the full N3 construct. P5 also showed a
weak interaction with the  - but not the  -appendage do-
main. Looking at the two peptides that bound with highest af-
finity to the  -appendage domain (P3 and P5), we concluded
that Fxx[F/W] was a potential binding sequence. Using the
P3 and P5 peptide consensus, we searched for homologous se-
quences in the protein database and found  -synergin. Next,
we made a peptide of one of the homologous sequences from
 -synergin, and found that it bound with an affinity of 13
 M. This was the highest affinity for any of our peptides. We
now recompared the similarity between our two highest affin-
ity peptides,  -synergin-P1 and epsinR-P5, and came up with
the consensus DFxD[F/W]. The highest scoring protein in
the database is now  -synergin, with three copies of this mo-
tif.  -synergin has already been characterized as a  -adap-
tin binding partner (Page et al., 1999) and thus, with this
work, we identify a binding site within the protein for the
 -appendage. Rabaptin5 (Nogi et al., 2002) and Eps15 (Kent
et al., 2002) are also proposed to interact directly with the
 -appendage domain. Both these proteins contain homolo-
gous sequences to the above consensus. Looking through the
protein database for other potential  -adaptin appendage
binding partners, we get a high score for an uncharacterized
EF-hand protein (NP_060127) with three copies of this mo-
tif. This protein also contains potential clathrin-binding mo-
tifs and multiple DDF motifs, and thus, this is a future candi-
date to join the ranks as a  -appendage interacting protein.
Figure 6. Subcellular localization of epsinR. As a 
convention throughout the figure, myc-epsinR and 
mutants are labeled green and the endogenous 
proteins are labeled red. (A) Endogenous epsinR 
shows a perinuclear enrichment (Ai) with a very 
different distribution to Myc-epsin1 (green in Aii), 
but it colocalizes with overexpressed Myc-epsinR 
(green in Aiii). Colocalization is orange/yellow. 
We observed that the epsinR perinuclear compart-
ment was frequently enlarged, and in extreme 
examples much of the overexpressed epsinR was 
accumulated there (Aiv). Endogenous epsinR is 
also accumulated in this compartment (Aiv). (B) 
Colocalization of Myc-epsinR with endogenous 
AP1 (ii and v), transferrin (iii and x), clathrin (vi), 
GGA (vii), cation-independent mannose-6-phosphate 
receptors (M6P, viii), and TGN46 (ix). Panels v–x 
are closer views of the perinuclear regions of cells 
stained for overexpressed epsinR and the indicated 
marker. There is much orange/yellow color in the 
perinuclear region of the cell implying a great 
deal of colocalization, but precise colocalization 
is hard to define in this region because of the 
accumulation of so many compartments. Transferrin 
(panel x) is labeled blue and colocalization with 
AP1 is cyan. (C and D) Colocalization of various 
markers with the D34G   R67L and the L10E 
mutants of epsinR, respectively. Labeling is the 
same as in B. Links to original images and extra 
data can be found at http://www.jcb.org/cgi/content/
full/jcb.200208023/DC1.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 EpsinR binds AP1 adaptors, clathrin, and PtdInsPs | Mills et al. 219
Clathrin assembly
EpsinR is enriched in CCVs (Fig. 3 B). Clathrin binding
to the truncations and mutants of N3 imply that there
may be multiple clathrin-interacting motifs, including
the one centered on D422. If this were the case, then it
might be expected that epsinR will promote clathrin cage
assembly by linking clathrin triskelia together. We and
others have previously shown that epsin1 binding to
membranes can promote clathrin recruitment and poly-
merization, and that this is due to the presence of multi-
ple clathrin-binding motifs (Ford et al., 2002; Kalthoff et
al., 2002a; and unpublished data). By analogy, epsinR
might be expected to assemble clathrin. We tested this in
comparison to AP180, which strongly exhibits this activ-
ity at neutral pH and with the  -appendage   hinge do-
main, which exerts this effect more strongly at a lower
pH (Owen et al., 2000; Ford et al., 2001). Under these
conditions, the N3 domain does not promote clathrin
cage assembly, and even antagonizes the limited assembly
by   -appendage     hinge domain at neutral pH. This
does not exclude an assembly activity of epsinR, as the
N3 construct does not include all the clathrin-binding ac-
tivity (Fig. 4 A), but the N1 construct gave similar re-
sults. We conclude that clathrin assembly is not a primary
function of this domain.
Subcellular localization of EpsinR
Epsin1 is brain-enriched, whereas epsinR is ubiquitous in its
tissue distribution (Fig. 3), and homologues are found in both
C. elegans and Drosophila. Thus, we used epsinR antibodies
to detect endogenous protein in COS cells. It showed a
perinuclear concentration with additional puncta distributed
throughout the cytoplasm (Fig. 6 Ai). These puncta were
completely distinct from those observed with overexpressed
epsin1 (Fig. 6 Aii). Overexpressed Myc-epsinR showed the
same expression pattern, although with a greater perinuclear
concentration (Fig. 6 Aiii). Overexpressed myc-epsinR also
overlapped with staining for other endogenous proteins (Fig.
6 B); AP1, perinuclear clathrin, GGA, M6P receptors and
TGN46 (but not the medial Golgi marker GM130 and the
lysosomal marker Lamp1; see http://www.jcb.org/cgi/content/
full/jcb.200208023/DC1). Strong overexpression of WT
epsinR led to enlarged perinuclear compartments (Fig. 6 Aiv).
We have previously shown that overexpression of epsin1 leads
to an inhibition of AP2/clathrin-coated vesicle formation
from the plasma membrane (see Fig. 3 d in Ford et al., 2002),
likewise, these enlarged epsinR positive compartments may be
due to a budding deficiency (Fig. 7 B). This phenotype be-
came stronger over time, thus, in these studies, we have been
careful not to prolong the overexpression.
The D34G   R67L mutation in the ENTH domain of
epsinR greatly weakened its binding to lipids (Fig. 2). These
same mutations in full-length epsinR resulted in the redistri-
bution away from the perinuclear region into irregularly sized
puncta (Fig. 6 C). Thus, the ENTH domain of epsinR is im-
portant for localization. These puncta were not aggregates of
epsinR, as they costained for the membrane protein TGN46
and perinuclear clathrin also redistributed to these spots. The
amount of clathrin and TGN46 in the large puncta was di-
rectly proportional to the amount of epsinR, judging from the
equivalent intensities of the stainings. We did not detect any
direct interaction of epsinR and the cytoplasmic tail of
TGN46 in vitro (unpublished data). AP1, GGAs, early endo-
some antigen 1 (EEA1), transferrin, and M6P receptors did
not follow the mutant and were not redistributed (links to
original images and extra data can be found at http://
www.jcb.org/cgi/content/full/jcb.200208023/DC1). Frac-
tionation studies showed that the D34G mutation resulted in
the loss of Golgi epsinR enrichment (Fig. S1).
Mutation of the L6 residue on helix zero of epsin1 has a
profound effect on lipid curvature (Ford et al., 2002). The
equivalent residue on epsinR is L10, and this was mutated to
a hydrophilic residue (L10E) and the protein was overex-
pressed (Fig. 6 D). The TGN enrichment was severely re-
duced. Thus, like epsin1, the hydrophobicity of helix zero is
important for the protein’s normal distribution. The pheno-
type was distinguished by large puncta around the nucleus
and in the cytoplasm, which cannot clearly be classified as a
known compartment. AP1 was found in these epsinR
puncta as a very diffuse stain, but we did not detect GGAs.
We also did not find EEA1, Lamp1, GM130, or M6P
receptors in the puncta (links to original images and extra
data can be found at http://www.jcb.org/cgi/content/full/
jcb.200208023/DC1). These puncta colocalized with clath-
rin and a minor component of TGN46, but most of the
TGN46 was still in its perinuclear compartment. Further-
Figure 7. Disruption of CCV trafficking from the TGN. (A) Over-
expression of Myc-epsinR caused mistargeting of pro-cathepsin D. 
COS cells, either untransfected (UTC) or transfected with WT 
Myc-epsinR or Myc  -appendage domain were pulse-chased with 
35S, and both-cell associated (C) and -secreted (S) cathepsin D were 
immunoprecipitated and gels were phosphorimaged. The secreted 
forms are indicated by the asterisks. (B) Reduced incorporation of 
the cation-independent M6P receptor into purified CCVs in epsinR 
transfected COS cells.T
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more, the intensities of epsinR and clathrin/TGN46 puncta
were equivalent, and there was a disruption of the perinu-
clear clathrin organization (Fig. 6 D). Given the partial re-
distribution of TGN46 with WT epsinR, D34G   R67L,
and the L10E mutants, we speculate that trafficking of this
transmembrane protein is affected by epsinR. Further
epsinR mutants are found at http://www.jcb.org/cgi/content/
full/jcb.200208023/DC1.
EpsinR is involved in vesicle budding between 
the TGN and endosomes
Given the enrichment of endogenous epsinR in Golgi frac-
tions and the distribution by immunofluorescence, we would
predict that at least one trafficking step in which epsinR is in-
volved is AP1/clathrin-mediated budding from the TGN.
Numerous proteins are incorporated into AP1/clathrin-
coated vesicles from the TGN, including the cation-indepen-
dent M6P receptor and the lysosomal hydrolase cathepsin D.
In mice deficient in the  1A subunit of AP1, the trafficking
of both the cation-independent M6P receptor and cathepsin
D is perturbed (Meyer et al., 2000). As epsinR has a high af-
finity for AP1, we tested whether overexpression of epsinR
could perturb cathepsin D trafficking. Cathepsin D is synthe-
sized as an inactive 53-kD glycosylated protein (pro-cathep-
sin) in the Golgi and trafficked to lysosomes, via late endo-
somes (direct pathway) or via the cell surface (indirect
pathway/secretion and reuptake). Pro-cathepsin D is de-gly-
cosylated and further cleaved in lysosomes to generate the ac-
tive 30-kD mature form. In mice deficient in the  1A sub-
unit of AP1, there is an increased secretion of glycosylated
cathepsin D into the medium due to a disruption of its traf-
ficking to the lysosome. We found that overexpression of
epsinR caused a  10-fold increase (n   4) in the quantity of
cathepsin D precursors secreted into the medium versus un-
transfected control cells (Fig. 7 A). Overexpression of the
 -appendage domain also perturbed normal trafficking, though
not to the same extent (Fig. 7 A), whereas epsin1 and the
ENTH domain of epsinR had no effect (unpublished data).
Thus, WT epsinR overexpression disrupts this AP1-depen-
dent process in line with our observations of the enlarged
perinuclear compartments with WT protein overexpression.
The cation-independent M6P receptor also traffics from the
TGN via CCVs (Meresse and Hoflack, 1993; Meyer et al.,
2000), and is enriched in purified liver CCV fractions (Fig. 3
B). We were not able to detect a bulk change in the distribu-
tion by immunofluorescence, but there was a reduction in re-
ceptor incorporation in purified CCVs from COS cells trans-
fected with epsinR (Fig. 7 B). This reinforces the argument
that epsinR functions in CCV budding from the TGN.
Discussion
Previously, we have proposed that epsin1 has a fundamental
role in generating the curvature of the clathrin-coated pit (Ford
et al., 2002). Epsin1 binds to clathrin and AP2 adaptors and to
plasma membrane PtdIns(4,5)P2. By sequence homology,
epsin2 and 3 are also likely to act in clathrin-mediated endocy-
tosis from the plasma membrane. In this paper, we show that
epsinR is involved in clathrin-mediated budding from internal
compartments. Consistent with this function, it binds to clath-
rin and AP1 adaptors and to PtdIns(4)P, and its distribution in
cells did not overlap with that of epsin1. In fact, most of the
clathrin puncta in transfected COS cells are accounted for
by a combination of epsin1 and epsinR puncta (see http://
www.jcb.org/cgi/content/full/jcb.200208023/DC1).
The clathrin/adaptor-binding domain of epsinR contains
multiple clathrin-binding sites and multiple DxF motifs that
are predicted to bind to adaptor appendage domains. It is now
generally assumed that these regions in the various endocytic
proteins are unfolded and the motifs act like hooks on a fish-
ing line to maximize the potential for ligand binding (Kalthoff
et al., 2002a). The simultaneous binding of multiple  - and/
or  -appendages to N3 supports this fishing line model. By
CD spectroscopy, the N3 construct is largely unstructured and
we did not detect any major change on binding of  -append-
age (Fig. S2). However, our results imply that limited folding
gives rise to the high affinity interactions. First, separate point
mutants of the two  -appendage binding sites in N3 (D349R
and D371R) both result in a reduction of the high affinity in-
teraction. Second, the peptide binding data do not reproduce
the high affinities achieved with the N3 construct.
In this paper, we have identified for the first time a
 -appendage binding motif, [D/E]FxD[F/W], present in
epsinR,  -synergin, and an uncharacterized EF-hand pro-
tein, NP_060127, that will be the subject of future investi-
gations. This motif should bind to a basic patch on the sur-
face of the  -appendage (Kent et al., 2002; Nogi et al., 2002),
and thus, the introduction of a negative charge into this patch
(L762E) disrupted the interaction (Fig. 4 C). The Drosoph-
ila epsinR homologue has two copies of EFxDF, whereas the
Drosophila epsin1 homologue has none. The C. elegans epsinR
homologue conserves the GFxDF as present in epsinR-P3.
To enable the study of epsinR function, we modeled its
ENTH domain on the structure of epsin1 ENTH bound to
Ins(1,4,5)P3. Mutations reduced the binding to lipids and to
purified Golgi membranes (Fig. 2 B and Fig. S1), and
showed the ENTH domain primarily determines the loca-
tion of the protein in cells, just as for epsin1 (Fig. 6). We
found that the lipid binding of epsinR was not strong enough
to enable us to do more biochemistry on the protein to assay
for clathrin recruitment and liposome tubulation. However,
this weaker affinity points to the importance of other factors
in the localization of the protein, perhaps multimerization
and/or the presence of other proteins. Arf could well play a
role in recruitment, as it does in the localization of the AP1
complex, OSPB and PtdIns 4-kinase to the Golgi (Godi et
al., 1999; Levine and Munro, 2002). Consistent with a role
for oligomerization, we noted that the N3 construct of
epsinR binds to full-length epsinR (Fig. 4 D). This is not due
to N3 self-association (Fig. S3; ultracentrifugation data).
Another key feature of the epsin1 ENTH domain is the am-
phipathic nature of helix zero with an exposed ridge of hydro-
phobic residues. This is preserved in epsinR and is likely ex-
tended at the NH2 terminus for another turn of the helix (Fig.
1 B and yellow shading in Fig. 1 C). We would propose that
epsinR, like epsin1, will fold this helix on binding to PtdInsP
and insert the amphipathic helix between the lipid head groups,
aiding membrane curvature during clathrin cage formation.
In this paper, we also propose that epsinR is functionally
equivalent to epsin1, but in CCV budding from the TGN/T
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endosomes rather than from the plasma membrane. We ob-
serve a trafficking defect in cathepsin D like that found in the
 1A-deficient cell line (Meyer et al., 2000). A budding defect
from the TGN is supported by the observation of enlarged
compartments on overexpression of epsinR (and especially
with the lipid-binding mutants, for example L10E) and the
disruption of M6P receptor incorporation into CCVs on
overexpression of epsinR. Our data strongly suggest that these
budding defects involve clathrin/AP1 trafficking pathways.
Having submitted this paper, other manuscripts have
been published or are in press where epsinR has been found
using a proteomics approach on purified CCVs (Wasiak et
al., 2002; Hirst et al., 2003) and by homology searches for
ENTH domain proteins (Kalthoff et al., 2002b). The au-
thors give various names to the same protein “enthoprotin,”
epsinR, and “clint,” respectively, and find a similar localiza-
tion in cells and clathrin/adaptor interactions. Also, a yeast
epsin–related protein has been shown to be required for
Golgi–endosome traffic (Duncan et al., 2003).
Materials and methods
Protein expression and purification
The cDNA for human epsinR (KIAA0171) was a gift from the Kazusa DNA
Research Institute, Chiba, Japan. Human epsinR ENTH (residues 1–169),
N1, N2, and N3 domains and their mutants, as well as full-length epsin1,
epsin1 N488, AP180 COOH terminus (residues 530–915), Eps15 COOH
terminus (residues 529–898), GGA1 appendage (residues 468–639), GGA2
appendage (residues 454–613), and the  -adaptin appendage domain (resi-
dues 701–938) were expressed as NH2-terminal GST fusion proteins (in
pGex4T2) in BL21 cells after IPTG induction overnight at 22 C. All GST fu-
sion proteins were purified from bacterial extracts by incubation with glu-
tathione-Sepharose beads, followed by extensive washing with 20 mM
Hepes, pH 7.4, 150 mM NaCl, and 1 mM DTT. The proteins were cleaved
by incubation for 2 h with thrombin, and further purified by passage over a
Q-Sepharose column. For ITC experiments, the protein was additionally
passed down a Superdex™ 75 gel filtration column and dialyzed into 100
mM Hepes, pH 7.4, 50 mM NaCl, and 2 mM DTT. Myc-tagged proteins (in
pCMV-myc) were used for COS-7 expression. Baculovirus expression and
purification of full-length AP180 was described previously (Ford et al.,
2001). The appendage domains of  -,  -, and  -adaptins (h- 2 appendage,
residues 700–937; h- 2 appendage   hinge, residues 616–937; h-  ap-
pendage, residues 704–822) and the GFP-oxysterol binding protein (OSBP,
a gift of S. Munro, MRC-LMB, Cambridge, UK) were expressed in BL21 cells
as NH2-terminal 6xHis fusion proteins (in pET or pTrcHis, respectively) and
purified by passage over nickel-NTA and then Q-Sepharose. Human p40
phox
PX domain protein was a gift of Olga Perisic, MRC-LMB. Purification of
CCVs and clathrin from rat brain and liver is described on http://
www.jcb.org/cgi/content/full/jcb.200208023/DC1. This preparation does
not exclude the presence of trace amounts of AP2 and AP180. COS cell
CCVs were purified from cracked cells passed through a 23-gauge needle
and then processed as described previously (Gaffet et al., 1997).
Transfections and antibodies
COS-7 cells were transfected using GeneJuice™ (Novagen) according to
the manufacturer’s protocol. 28 h after transfection, cells were transferred
to serum-free medium and incubated with biotinylated transferrin for 15
min before fixation with 4% PFA. EpsinR-transfected cells were detected
using either a polyclonal anti-Myc antibody (green in merged images; Cell
Signaling), or an mAb (9E10; Sigma-Aldrich). AP1 distribution was fol-
lowed using a  -adaptin mAb (100–3, red in merged images), and biotin-
ylated transferrin was detected with labeled streptavidin (blue in merged
images). Other antibodies used were as follows: polyclonal Epsin1 DPW
domain (Ra14), monoclonal clathrin (X22, a gift of B. Pearse, MRC-LMB),
monoclonal EEA1 (Transduction Laboratories), polyclonal cation-indepen-
dent M6P receptor (1001, a gift of P. Luzio, Cambridge Institute for Medi-
cal Research, Cambridge, UK), and polyclonal GGA1 and 2 antibodies (a
gift of J. Hirst and M. Robinson, Cambridge Institute for Medical Research).
Cells were mounted and imaged using a confocal system (Radiance; Bio-
Rad Laboratories). The Ra43 antibody raised against an NH2-terminal
epsinR construct crossreacts with a band of 180 kD (likely AP180, which
has a homologous NH2-terminal domain). By immunofluorescence, it does
not recognize overexpressed epsin1, its closest homologue (Fig. 6 A), and
the distribution of the overexpressed epsinR is the same as the endogenous
protein, even in cells where there is an enlarged perinuclear compartment.
The antibody works better on purified fractions than in total homogenates.
We also raised another antibody against epsinR N3 that showed the same
staining pattern. Biosynthetic labeling of cathepsin D was as described
previously (Davidson, 1995), except that ProMix at 5  l/ml of medium
(Amersham Biosciences) was used for labeling.
Phospholipid binding
Protein binding to phospholipids was investigated in a protein lipid overlay
assay using PIP Strips™ (Echelon Biosciences Incorporated) according to the
manufacturer’s protocol. In brief, the membrane was blocked in TBST (10
mM Tris-HCl, pH 8.0, 150 mM NaCl, and 0.1% Tween 20 [vol/vol]   3%
BSA [wt/vol]) for 1 h at RT. Protein was added at 0.5  g/ml in TBST   BSA
and incubated for 1 h at RT. The membrane was washed three times for 10
min in TBST   BSA. Proteins were detected by incubation with a 1/1,000 di-
lution of our polyclonal rabbit antibody Ra30 against the epsin1 ENTH do-
main, with a 1/1,000 dilution of our polyclonal rabbit antibody Ra43 for
wild-type and mutant epsinR ENTH and with a 1/1,000 dilution of a mono-
clonal mouse anti–GFP antibody (CLONTECH Laboratories, Inc.) for detec-
tion of His-GFP-OSBP in TBST   BSA, followed by incubation with anti–
rabbit or anti–mouse HRP conjugate (Bio-Rad Laboratories) in a 1/10,000
dilution and by ECL (Amersham Biosciences). Lipid specificity was tested with
a liposome pelleting assay as described on http://www.jcb.org/cgi/content/
full/jcb.200208023/DC1. Proteins were detected with Coomassie stain.
Isothermal titration calorimetry
Binding of epsinR constructs and peptides to  -,  -, and  -adaptin append-
age domains were investigated by ITC (Wiseman et al., 1989) using a VP-
ITC (MicroCal, Inc.). All experiments were performed in 100 mM Hepes,
pH 7.4, 50 mM NaCl, and 2 mM DTT at 10 C. The peptides or proteins
were injected from a syringe in 40–50 steps up to a 3–4-fold molar excess.
The cell contained 1.4 ml protein solution, and typically, the ligand was
added in steps of 4–8  l every 3.5 min. Concentrations were chosen so
that  -,  -, and  -adaptin appendage domains were at least fivefold higher
than the estimated dissociation constant, if possible. The epsinR protein or
peptide ligands were again at least 10-fold more concentrated than the ear
domains. The heat of dilution of the ligand was subtracted from the data
before fitting. Titration curves were fitted to the data using the ORIGIN
program (MicroCal, Inc.) yielding the stoichiometry N, the binary equilib-
rium constant KA (  K D
 1) and the enthalpy of binding. The entropy of
binding  S  was calculated from the relationship  G     RT lnKA and the
Gibbs-Helmholtz equation.
Clathrin assembly and sedimentation assays
Purified clathrin was dialyzed into 0.1 M MES, pH 6.5, 1 mM EGTA, 0.5
mM MgCl2, and 1 mM DTT, and centrifuged at 100,000 g for 25 min to re-
move aggregates. Clathrin was incubated with proteins or an equivalent
volume of buffer at 4 C for 10 min and spun at 100,000 g in a rotor (model
TLA100; Beckman) for 25 min. Final protein concentrations were as fol-
lows: clathrin, 0.3  M; epsinR N3, 50  M;  -appendage   hinge domain,
40  M; AP180, 0.3  M.
Online supplemental material
Fig. S1 shows the enrichment of epsinR in Golgi membrane fractions along
with the cation-independent M6P receptor. It also shows that the epsinR
lipid-binding mutant, D34G    R67L, no longer associates with Golgi
membrane fractions. Fig. S2 shows that the N3 construct of epsinR is
largely unstructured according to CD spectroscopy. Fig. S3 shows that
epsinR is a monomer at all concentrations tested by analytical ultracentrif-
ugation. Table SI supplies the detailed thermodynamic parameters mea-
sured by isothermal calorimetry for binding of the N3 construct of epsinR
to various ligands. Original immunofluorescence images are presented as
web pages that allow the reader to see individual channels and larger
fields of cells. Additional antibody stains and mutants are also presented.
Online supplemental material available at http://www.jcb.org/cgi/content/
full/jcb.200208023/DC1.
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